Daniëlle M. Gerlag

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

Daniëlle M. Gerlag, Karim Raza, Lisa G. M. van Baarsen et al. · Annals of the Rheumatic Diseases · 2012 · 470 citations · Full text

Life Sciences, Immunology, Autoimmunity +15

Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis

Jasper J. Haringman, Daniëlle M. Gerlag, Aeilko H. Zwinderman et al. · Annals of the Rheumatic Diseases · 2004 · 464 citations · Full text

Medicine, Immunology, Pathology +17

Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study

Daniëlle M. Gerlag, M. Safy, Karen I. Maijer et al. · Annals of the Rheumatic Diseases · 2018 · 287 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

Jasper J. Haringman, Daniëlle M. Gerlag, Tom Smeets et al. · Arthritis & Rheumatism · 2006 · 255 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial

Clarissa E. Vergunst, Daniëlle M. Gerlag, Luba Lopatinskaya et al. · Arthritis & Rheumatism · 2008 · 236 citations

Life Sciences, Immunology, Pharmacology +17